Summary: After 3 years of Brexit withdrawal negotiations, the UK is officially no longer a member of the European Union. Clinical sponsors with active and planned studies in the EU...

Developing a clinical supply strategy early is key to minimizing risk and avoiding delays when implementing and executing accelerated study timelines.

As the number of global scale clinical trials continues to grow, sponsors will need to implement methods to ensure their protocols are executed properly.

Clinical supply packaging strategies can greatly impact the ability to properly execute study protocols.

Summary: In 2018, over 40% of new clinical studies had sites in the APAC region this trend is expected to continue to grow in the coming years.

Summary: Due to the influx of COVID-19 related therapies being expedited into clinical testing, studies in other areas are either proceeding with heightened caution or are essentially being...

Summary: Catalent and Fierce Pharma surveyed 234 individuals involved in clinical supply and clinical operations to better understand the industry perception around importance of having a direct-to-patient option...

Summary: Proactive clinical supply risk evaluation and tailored strategies to support on-time study start-up for small and mid-sized sponsors...

Summary: The Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies. Managing a clinical supply distribution strategy within APAC...

Summary: After 3 years of Brexit withdrawal negotiations, the UK is officially no longer a member of the European Union. Clinical sponsors with active and planned studies in the EU...